[ad_1]
The MoU was signed by DoH Deputy Minister Dr Jamal Mohammed Al Kaabi and ADQ Executive Director of Healthcare and Life Sciences Fahad Al Qassim in the presence of DoH Chairman Abdulla bin Mohammed Al Hamed.
As part of the memorandum of understanding, the parties will establish a steering committee to manage and oversee all projects that will deliver results from the collaboration in clinical research, evidence generation and innovation, with a view to enhancing synergies across fields by leveraging the assets and capabilities of both parties. Research and innovation value chain.
The council will lead a governance system and roadmap led by representatives from all parties to handle individual workflows in an efficient and flexible manner.
Additionally, DoH and ADQ seek to enhance synergies between UAE start-ups to improve healthcare outcomes and contribute to Abu Dhabi’s globally competitive knowledge-based economy.
DoH supports start-ups at different stages of development, from ideation to introduction and expansion into international markets.
Dr Al Kaabi said: “As directed by our wise leadership, our collaboration with leading entities such as ADQ echoes Abu Dhabi’s ongoing efforts to position itself as a leading life sciences destination and an incubator and accelerator for innovation.
“Through this agreement, we aim to further enhance our research capabilities to increase the resilience and sustainability of the industry, which reflects the quality of healthcare services provided to the Abu Dhabi community.”
For his part, Al Qassim said: “As part of a transformational strategy aimed at further improving the quality of outcomes in the healthcare industry, ADQ continues to demonstrate support for prestigious events such as GITEX to explore opportunities and work collaboratively with global strategic partners for healthcare Laying the foundation for a future driven by technology, innovation and artificial intelligence.”
[ad_2]
Source link